体外超滤治疗心力衰竭液体负荷过重:现状与进一步研究展望
简化超滤装置可在低急症住院环境中移除液体,但安全性和有效性结果矛盾;固定速率超滤在肌酐升高后启动不优于标准治疗且并发症更多,而根据生命体征和肾功能调整超滤速率的数据提示可能更有效减轻充血并减少心衰事件。
要点
- 充血是心衰住院主因,再住院提示不良结局独立于年龄和肾功能。
- 固定速率超滤在治疗致肌酐升高后启动不优于标准治疗且并发症更多。
- 依据生命体征和肾功能调整超滤速率的数据提示可能更有效减轻充血。
核心结论
- 超滤关键方面仍不明确,鉴于充血负担和早期可调超滤持续获益的数据,亟需进一步研究。
研究设计与样本
- 综述性文章,检索范围原文未报告。
主要发现
- 持续性充血在预测不良心衰结局上胜过血清肌酐升高。
- 简化超滤装置可在低急症住院环境移除液体,但安全性和有效性结果矛盾。
- 固定速率超滤在治疗致血清肌酐升高后启动不优于标准治疗且并发症更多。
- 与利尿剂相比,一些数据提示按生命体征和肾功能调整超滤速率可能更有效减轻充血并减少心衰事件。
关键数值与推荐
- 原文未报告关键数值标准。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未述局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
More than 1 million heart failure hospitalizations occur annually, and congestion is the predominant cause. Rehospitalizations for recurrent congestion portend poor outcomes independently of age and renal function. Persistent congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No decongestive pharmacological therapy has reduced these harmful consequences. Simplified ultrafiltration devices permit fluid removal in lower-acuity hospital settings, but with conflicting results regarding safety and efficacy. Ultrafiltration performed at fixed rates after onset of therapy-induced increased serum creatinine was not superior to standard care and resulted in more complications. In contrast, compared with diuretic agents, some data suggest that adjustment of ultrafiltration rates to patients' vital signs and renal function may be associated with more effective decongestion and fewer heart failure events. Essential aspects of ultrafiltration remain poorly defined. Further research is urgently needed, given the burden of congestion and data suggesting sustained benefits of early and adjustable ultrafiltration.
引用
- Costanzo MR, Ronco C, Abraham WT, et al. Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research. J Am Coll Cardiol. 2017. PMID: 28494980. doi:10.1016/j.jacc.2017.03.528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。